A First-in-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), as Monotherapy and in Combination with Erlotinib in Advanced Cancer.
about
Progress of antibody-based inhibitors of the HGF-cMET axis in cancer therapy.Chemotherapy for hepatocellular carcinoma: The present and the future.A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer TherapyA non-randomized, open-label, single-arm, Phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancer.The persistent promise of combining HGF/MET and EGFR inhibition in non-small cell lung cancer.New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness.Exploring Landscape of Drug-Target-Pathway-Side Effect Associations.Immunotherapies: Exploiting the Immune System for Cancer Treatment.A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancerStatus of Agents Targeting the HGF/c-Met Axis in Lung Cancer
P2860
Q37739477-AC2C8CB3-2790-46E7-A042-A3348A4FAA10Q38639762-D1AB111B-694E-47C4-A367-83A40D75CC44Q41574359-130FF967-C2EB-4943-850F-617E3ED9D61BQ44303811-B59AD598-3F52-4623-A0DB-E5D18595BB29Q46073425-B48FA15D-9F12-4008-87BD-A799E0C017FFQ47221234-799D29A5-F69D-4A80-9A3C-291D7A6B2E32Q55291267-02951FA9-4F2C-4625-BEA4-39A05585F9C8Q55362851-A44566DC-0E70-4976-A595-D296B6BF4754Q57162835-7CDE53F3-ADCE-45F0-9714-81658C3692EBQ58726253-6C82FF0C-31B4-4DF7-84CE-958688B8B13B
P2860
A First-in-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), as Monotherapy and in Combination with Erlotinib in Advanced Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
A First-in-Human Phase I Study ...... Erlotinib in Advanced Cancer.
@en
A First-in-Human Phase I Study ...... Erlotinib in Advanced Cancer.
@nl
type
label
A First-in-Human Phase I Study ...... Erlotinib in Advanced Cancer.
@en
A First-in-Human Phase I Study ...... Erlotinib in Advanced Cancer.
@nl
prefLabel
A First-in-Human Phase I Study ...... Erlotinib in Advanced Cancer.
@en
A First-in-Human Phase I Study ...... Erlotinib in Advanced Cancer.
@nl
P2093
P1476
A First-in-Human Phase I Study ...... Erlotinib in Advanced Cancer.
@en
P2093
Alain P Algazi
Brian Moser
James E Wooldridge
Jay Tuttle
Jonathan W Goldman
Lee S Rosen
Michaela Banck
P Kellie Turner
Volker Wacheck
P304
P356
10.1158/1078-0432.CCR-16-1418
P407
P577
2016-10-10T00:00:00Z